SCHEDULE 13G: Pacific Health Century International Group Discloses 5.62% Stake in Hong Kong Pharma Digital Technology Holdings Ltd
Beneficial Ownership Disclosure
Pacific Health Century International Group has filed a Schedule 13G, disclosing beneficial ownership of 5.62% of Hong Kong Pharma Digital Technology Holdings Ltd's Ordinary Shares as of March 31, 2025.
Summary
- Pacific Health Century International Group, a British Virgin Islands entity, has reported beneficial ownership of 617,850 Ordinary Shares of Hong Kong Pharma Digital Technology Holdings Ltd.
- This ownership represents 5.62% of the Issuer's outstanding Ordinary Shares.
- The percentage is calculated based on 11,000,000 Ordinary Shares issued and outstanding as of March 31, 2025.
- The Reporting Person holds sole voting power and sole dispositive power over all 617,850 shares.
- The filing was made under Rule 13d-1(c) of the Securities Exchange Act of 1934.
Sentiment
Score: 5
Explanation: The document is a factual regulatory filing disclosing beneficial ownership and does not contain information that would inherently indicate a positive or negative sentiment towards the company's performance or prospects.
Future Outlook
This document is a beneficial ownership disclosure and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing is a routine disclosure of a significant ownership stake by an institutional investor, common in the financial markets. It does not provide specific insights into broader industry trends or competitive landscape, but rather details a specific ownership position within the pharmaceutical digital technology sector.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant ownership stake held by Pacific Health Century International Group, which can influence perceptions of institutional interest and control.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires the filing of this statement, indicating the beneficial ownership stake. |
| 06/05/2025 | Date the Schedule 13G statement was signed and filed. |
Keywords
Hong Kong Pharma Digital Technology Holdings Ltd, Pacific Health Century International Group, Schedule 13G, Beneficial Ownership, Ordinary Shares, SEC Filing, Shareholder Disclosure, G6365B104
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.